Fluoride toothpaste prevents cavities; the IQ concern involves far higher fluoride intake.

1. Concern (minor) Sourcing is strong and transparent

   Cite the Texas AG's Sept 15, 2025 release or Colgate's own statement for the packaging change instead of relying only on DentistryIQ trade press.

   Sourcing is predominantly primary or high-quality: two Cochrane reviews, an NTP monograph, a peer-reviewed meta-analysis, CDC MMWR, the federal regulation text, the FDA press release, the Texas AG release, and NHS Scotland guidance. Each source states its role and is tied to specific evidence items, with DOIs. The one weak spot is the Colgate packaging change. It rests on a DentistryIQ trade-press report even though a primary source was readily available: DentistryIQ's own reference 2 is the Texas AG's 'September 15, 2025' release announcing the 'historic agreement'. This is a peripheral claim, so the concern is Minor. Transparency note: five sources (Walsh, Wong, Taylor, Whitford, and Wright, which returned empty text) have no archived copy and were blocked for server-side reading. They are identifiable by DOI, but the article's key benefit and fluorosis figures could not be checked against stored text. Confidence: High.

   About source:colgate-packaging-2025, evidence:label-and-2025-actions The finding

2. Concern (minor) Context is complete

   Note that the FDA's Oct 2025 announcement cited the IQ meta-analysis and gut-microbiome concerns as reasons, not only the swallowing of supplements.

   The article covers benefit, fluorosis, acute toxicity, IQ and regulation, and states its scope (no water-fluoridation policy, no 5,000 ppm products). It omits some context from its own FDA source. The FDA press release says it 'recognizes other preliminary but potentially concerning data on risks, such as a recent meta-analysis suggesting increased fluoride exposure is associated with decreases in IQ'. It also gives a gut-microbiome rationale and says a Cochrane review found fluoride 'did not reduce dental caries in baby teeth'. The article frames the 2025 actions as targeting 'how much fluoride children swallow'. That is accurate in scope, but readers would benefit from knowing the regulator explicitly invoked the IQ concern, which is the heart of the claim under review. The article could then explain why that rationale does not extend to toothpaste. Smaller gaps: (a) the claim's 'neurotoxin' wording is never addressed directly; the article could say fluoride is neurotoxic at high doses and that the dispute is about dose. (b) DentistryIQ reports that the JAMA Pediatrics meta-analysis was criticized in an accompanying editorial (Levy). (c) U.S. labeling (21 CFR 355.50(d)(1)(ii)) says 1,500 ppm paste is not for under-6s without professional direction, which is relevant to the stronger-paste arithmetic. None of these changes the overall impression. Confidence: Medium-High.

   About evidence:label-and-2025-actions, source:fda-ingestible-fluoride-2025, conclusion The finding

3. Concern (minor) Framing is fair and neutral

   Soften the title and answer ('far higher', 'much higher drinking-water exposures') to match the conclusion's admission that urinary-fluoride associations extend to lower levels.

   The body is balanced. It takes the NTP finding seriously ('deserves to be taken seriously'), concedes the urinary finding 'does not cleanly exonerate toothpaste swallowed in excess', and calls the low-dose question 'open'. The headline and answer are more one-sided. The title says 'the IQ concern involves far higher fluoride intake'. The answer says 'IQ effects were linked to much higher drinking-water exposures'. But NTP's threshold of 1.5 mg/L is about twice the 0.7 mg/L U.S. level, not 'far higher'. And per the NTP page, the meta-analysis 'found that fluoride exposure was associated with lower IQ scores at levels below 1.5 mg/L fluoride measured in urine or drinking water' in high-quality studies. A reader who stops at the headline would take away more reassurance than the article's own conclusion supports. The practical bottom line (toothpaste used as directed is safe; limit what young children swallow) is unchanged, so this is Minor. The original claim is stated plainly and the objections are presented fairly. The article does not identify who makes the claim, which is acceptable for a widely circulated claim. Confidence: Medium-High.

   About conclusion, evidence:ntp-iq-review The finding

4. Pass Central claims are accurate

   Summary: the article rates as Misleading the claim that fluoride toothpaste is a neurotoxin that lowers children's IQ, arguing that toothpaste prevents decay, that the measured risks of normal use are mild fluorosis and (rarely) acute poisoning, and that the IQ findings concern higher total intake. Claim ratings: (1) Toothpaste of 1,000 ppm or more reduces decay (Walsh 2019, 96 trials): True by my own knowledge. The snapshot could not be read (HTTP 403), but this is a well-established, uncontested finding. (2) The ADA review found benefit and a risk of mild fluorosis in under-6s: Mostly True. The source returned empty text, so it is unverified, but it agrees with what CDC MMWR says about fluorosis risk. (3) The 2024 Cochrane fluorosis figures (43 studies, 32,181 children; 1,000 ppm or more at ages 1 to 2 probably increases fluorosis, mostly mild): Unverifiable (403). The direction agrees with CDC and Childsmile ('reduce the risk of mild fluorosis'). (4) About 38% of 3- to 6-year-olds used more than a pea-sized amount: True. CDC Table 3 gives 20.6% half load plus 17.8% full load, and the text says '>38%'. (5) NTP found, with moderate confidence, lower IQ above 1.5 mg/L, with insufficient data at 0.7 mg/L and a total-exposure scope: True, matching the NTP page word for word. (6) Taylor 2025 found about 1.6 IQ points per 1 mg/L urinary fluoride, 74 studies, 52 at high risk of bias, none in the U.S.: True per the NTP page ('1.63 IQ points'; '52 were rated as low quality'). 'No significant association with drinking water below 1.5 mg/L' is Mostly True. The NTP page says high-quality studies showed associations below 1.5 mg/L in urine or drinking water, but 'few studies, and therefore uncertainty' for drinking water alone. The Taylor text was unreadable. (7) Dose arithmetic: True. 1,000 ppm = 1 mg/g, so 0.25 g = 0.25 mg; 10 kg x 5 mg/kg = 50 mg = 50 g, about 200 peas. 1,450 ppm needs about 31% less. Childsmile confirms 5 mg/kg and 'three quarters of a tube of 1000ppm toothpaste' for 15 kg. (8) Label text: True; it matches 21 CFR 355.50(c)(1) exactly. (9) FDA Oct 31, 2025 action on ingestible products for under-3s and low/moderate-risk children: True. (10) Texas AG CIDs on May 1, 2025, and the Colgate packaging change: True per both sources. Finding label: Misleading fits. The claim has a real kernel (a poison warning exists, and NTP found an association) but draws a false conclusion about normal use. Confidence: Medium-High. Items 1 to 3 and the drinking-water subresult rely on sources the server could not read.

5. Pass Claims are supported and labeled

   Every evidence item names its sources, and the conclusion's claims trace to them: benefit to walsh-cochrane-2019 and wright-jada-2014, fluorosis to wong-cochrane-2024, amounts to cdc-mmwr-2019, IQ to ntp-monograph-2024 and taylor-jama-pediatrics-2025, toxicity to whitford-2011 and childsmile, and labels and actions to the CFR, FDA, Texas AG and DentistryIQ. Inference is labelled as inference. The dose comparisons are flagged as 'FactHub's own arithmetic' with inputs shown. The article separates what the urinary finding cannot show ('cannot clear excess swallowing, and it also cannot show that correctly used toothpaste causes harm') from what is established. The negative claim 'No study isolated toothpaste' is an inference supported by NTP's statement that the review 'was designed to evaluate total fluoride exposure from all sources'. It is reasonable but cannot be fully verified from the sources. Confidence: High.

6. Pass Uncertainty is stated

   Uncertainty is stated explicitly and weighed. The conclusion splits confidence: 'High for cavity prevention and for the dose arithmetic; moderate for how much swallowed toothpaste contributes to the unresolved low-dose IQ question'. It says whether typical U.S. intake affects cognition 'is open'. Each evidence item carries a limitation that matches the sources: CDC self-report and no fluoride-type recording (matches the MMWR limitations), NTP's association-not-causation scope and high risk of bias in 52 of 74 studies (matches the NTP page), the 5 mg/kg figure being a threshold rather than a precise boundary, and regulatory actions being policy rather than new evidence. Conflicting evidence on IQ is presented on both sides, with reasons for its weight (non-U.S. settings, risk of bias, no toothpaste-specific studies). The headline overstatement is treated under framing-fair rather than here, because the body does not present contested evidence as settled. Confidence: High.

Coverage: Read the article payload in full (claim, finding, answer, summary, conclusion, 7 evidence items with limitations, objections, method, 12 sources). Readable source snapshots: cdc-mmwr-2019, ntp-monograph-2024 (the NTP page, including the meta-analysis summary), childsmile-managing-fluoride, cfr-355-50, fda-ingestible-fluoride-2025, texas-ag-toothpaste-2025 and colgate-packaging-2025, all archived copies. Not readable: walsh-cochrane-2019, wong-cochrane-2024, taylor-jama-pediatrics-2025 and whitford-2011 (HTTP 403, no Wayback capture), and wright-jada-2014 (fetch succeeded but returned empty text). Claims resting only on those sources (the Walsh trial counts, the Wong 2024 study counts and conclusions, Taylor's drinking-water subgroup result, Whitford's characterisation) were checked for consistency against readable sources and my own knowledge, but not verified against stored text. The full NTP monograph PDF was not read; only the NTP landing page was. No live web search was used.

1. Concern (minor) Rates the real claim

   Address the claim's 'neurotoxin' label directly (is fluoride neurotoxic at some dose?) and rate the claim as circulating, not only 'used as directed'.

   The claim circulates as: fluoride in toothpaste is bad for you, it is 'a neurotoxin that lowers children's IQ', and the poison warning proves it. Method step 1 narrows this to 'whether fluoride in toothpaste is harmful when used as directed', and the answer says 'Used as directed, fluoride toothpaste is safe'. A reader repeating the claim usually means toothpaste as children actually use it, and the article's own CDC item says about 38 percent of 3-to-6-year-olds use more than recommended. To its credit, the conclusion does discuss over-swallowing and says the urinary research 'does not cleanly exonerate toothpaste swallowed in excess', so it does not rate a strawman. But it never directly answers the 'neurotoxin' component: whether fluoride is a neurotoxicant at some exposure (which the NTP finding at >1.5 mg/L arguably implies), and therefore which part of the claim holds a kernel of truth. The mismatch is small and the conclusion stays within scope (toothpaste, children, current U.S. context), so Minor.

   About conclusion, method:1 The finding

2. Concern (material) Confidence matches the evidence

   Revise title and answer: 'far higher intake' contradicts the article's own urinary-fluoride evidence at lower levels; and overall High confidence exceeds the Moderate given for the IQ core.

   The title says 'the IQ concern involves far higher fluoride intake' and the answer says 'IQ effects were linked to much higher drinking-water exposures'. The article's own evidence item ntp-iq-review reports that the 2025 JAMA Pediatrics meta-analysis 'found an inverse association with urinary fluoride, about 1.6 IQ points per 1 mg/L, including at lower urinary levels', and the conclusion concedes this 'does not cleanly exonerate toothpaste swallowed in excess' and that whether typical U.S. intake affects cognition 'is open'. The headline and answer therefore state the finding more strongly than the evidence: the body says 'unresolved at low doses', the title says 'far higher'. Also, 1.5 mg/L is roughly twice the 0.7 mg/L U.S. level, which hardly supports 'far higher', and the comparison is to water while the claim is about toothpaste. Separately, the overall confidence is 'High', yet the conclusion itself gives only 'moderate' confidence for the IQ component, which is the core assertion of the claim being rated; High applies to cavity prevention and dose arithmetic, which are not what the claim disputes. Limitations are otherwise well stated (risk of bias, China-heavy studies, same research group). I would keep Misleading but at Moderate overall confidence, with a title like 'IQ findings involve higher total intake; toothpaste has not been isolated.' A reader of the title and answer would believe the low-dose question is settled, so Material.

   About conclusion, evidence:ntp-iq-review, limitation:ntp-iq-review The finding

3. Concern (minor) Strongest objections answered

   Quantify toothpaste's share of young children's total fluoride intake and address whether low-risk-of-bias cohorts show IQ associations at lower exposures.

   The objections section covers the poison label, the NTP finding, topical-only reasoning, FDA action, and fluorosis, each answered with the article's evidence rather than dismissal. The strongest objection, that low-level total intake (urinary fluoride) is associated with lower IQ and swallowed toothpaste contributes to it, is not in the objections list (the NTP response mentions only the 1.5 mg/L water finding) but is answered candidly in the conclusion. Two gaps remain. First, the article does not address how much of a young child's total fluoride intake comes from swallowed toothpaste compared with water and diet; without that, 'total intake, not toothpaste' cannot tell the reader whether toothpaste is a minor or major contributor. Second, the conclusion discounts the IQ literature partly because 'many were rated at high risk of bias' and none were U.S.-based; the article does not address whether the association persists in the studies rated at low risk of bias, including prospective birth cohorts in Canada and Mexico at lower exposures. These are things the article should answer; they do not overturn the rating because the conclusion already concedes the low-dose question is open. Minor.

   About conclusion, evidence:ntp-iq-review, limitation:ntp-iq-review The finding

4. Concern (minor) Evidence is independent

   Note likely overlap: the ADA 2014 review and Cochrane 2019 pool many of the same trials, and Childsmile's 5 mg/kg threshold likely derives from the same toxicology literature as Whitford.

   The article handles the most obvious dependency well: NTP 2024 and Taylor 2025 come from the same research group and are merged into one evidence item whose limitation says 'Both analyses come from the same federal research group'. Two other pairs are presented as separate support without noting overlap. The benefit case rests on cochrane-toothpaste-trials (96 RCTs, 1955-2014) and ada-under-six-review (2014 meta-analysis); a 2014 systematic review of fluoride toothpaste in children very likely draws on many of the same older trials, so they are not fully independent confirmations. Within acute-toxicity-dose, Childsmile is described in the sources as 'chosen as an independent non-U.S. source', but both it and Whitford use the same 5 mg/kg 'probably toxic dose', which is one threshold from a shared literature rather than two independent estimates. Independent support still remains (fluorosis review, CDC survey, regulatory records, and the arithmetic itself), so Minor.

   About evidence:cochrane-toothpaste-trials, evidence:ada-under-six-review, evidence:acute-toxicity-dose The finding

5. Pass Rating follows from the evidence

   Before reading the label I would rate this Misleading: the claim bundles real facts (a poison-control label exists per 21 CFR 355.50; NTP found an IQ association at drinking-water fluoride above 1.5 mg/L; Taylor 2025 found an urinary-fluoride association) with a false inference that toothpaste as used lowers IQ and that the label reflects that. The evidence as stated: no study isolates toothpaste (limitation:ntp-iq-review), the label targets accidental large ingestion (acute-toxicity-dose: ~200 pea-sized amounts for a 10 kg toddler), and the documented normal-use harm is mostly mild fluorosis. 'False' would be too strong given the genuine kernel and the open low-dose question the article itself concedes; 'Mixed' would overweight a hypothesis with no toothpaste-specific evidence. The article's 'Misleading' matches. The answer ('Used as directed, fluoride toothpaste is safe') is consistent with the label, though its second clause is addressed under confidence-calibrated.

Coverage: Examined the full article payload: claim, title, answer, finding (Misleading), confidence (High), summary, context, editorial note, conclusion, all seven evidence items with methods, institutions, years and limitations, five objections, five method steps, and source names/titles. Per the Skeptic prompt, source snapshots were not read; whether sources say what the article claims was not assessed (Source Checker's remit). Outside knowledge was used only to name objections the article should answer (toothpaste share of total intake; low-risk-of-bias birth cohorts; trial overlap), not as proof.

1. Concern (minor) Quotes and figures match

   Evidence label-and-2025-actions says the rule tells parents of under-2s to supervise to minimize swallowing; 21 CFR 355.50(d)(1) applies that to children under 6.

   In the sources I could read, the figures match. CDC: 5,157 children, '>38%' of 3-6-year-olds used a half or full load (20.6% + 17.8%), pea-sized = 0.25 g. The article's 'about 38 percent' is fine. NTP: 1.5 mg/L, 0.7 mg/L, 52 of 74 studies at high risk of bias, none in the U.S., and '1.63 IQ points' per 1 mg/L urinary fluoride, rounded to 'about 1.6'. Childsmile: 5 mg/kg, 15 kg child, 75 mg, three-quarters of a tube of 1000 ppm. The FactHub arithmetic is internally correct: 0.25 g x 1,000 ppm = 0.25 mg; 10 kg x 5 mg/kg = 50 mg = 50 g = 200 pea-sized amounts. FDA date (Oct 31, 2025), Texas AG date (May 1, 2025) and the CFR warning wording all match. One imprecision: the article says the rule 'tells parents of children under 2 to consult a dentist or doctor and to supervise brushing to minimize swallowing.' The CFR text reads 'Instruct children under 6 years of age in good brushing and rinsing habits (to minimize swallowing). Supervise children as necessary... Children under 2 years of age: Consult a dentist or doctor.' The supervision and minimize-swallowing instruction covers under-6s, not specifically under-2s. That understates the rule's scope but doesn't change the item's point. I could not check figures attributed only to unreadable sources: Walsh (96 trials, 1955-2014, 55 studies), Wong 2024 (43 studies, 32,181 children, 1,968 in two RCTs), Taylor ('45 of 74 from China', no significant drinking-water association below 1.5 mg/L) and Whitford.

   About evidence:label-and-2025-actions, source:cfr-355-50 The finding

2. Concern (minor) Sources represented fairly in context

   Evidence ntp-iq-review says no significant drinking-water association below 1.5 mg/L; the NTP page calls this uncertain (few studies) and reports high-quality-study associations below 1.5 mg/L.

   Evidence ntp-iq-review says the 2025 meta-analysis 'found no significant association with drinking-water fluoride below 1.5 mg/L'. The NTP page (archived), describing that same meta-analysis, says: 'Using data from the high-quality studies, the analyses found that fluoride exposure was associated with lower IQ scores at levels below 1.5 mg/L fluoride measured in urine or drinking water. However, there were few studies, and therefore uncertainty, in the relationship below 1.5 mg/L when fluoride was measured only in drinking water.' The article's wording reads as a negative finding where the cited NTP summary describes uncertainty. The primary source for the phrase (Taylor, JAMA Pediatrics) returned 403 and could not be read, so the wording may be accurate to the paper. Elsewhere the article already says the urinary results do not exonerate toothpaste, so a careful reader's overall impression barely changes: Minor. Other readable sources are fairly represented. NTP's 'association ... does not prove a cause and effect' and total-exposure scope are reflected. The CDC report's limitations (self-report, fluoride type unspecified) appear in the article's limitation. The FDA release's other rationale (gut microbiome, lack of approval, a Cochrane finding of no benefit in baby teeth for ingestible fluoride, an IQ meta-analysis) all concerns ingested products. That fits the article's framing that the action targets swallowing, and the article correctly says it did not restrict toothpaste. DentistryIQ quotes Paxton calling the outcome a 'historic agreement'. The article's 'investigation, not a court finding' is still accurate. Context in walsh-cochrane-2019, wright-jada-2014, wong-cochrane-2024, taylor-jama-pediatrics-2025 and whitford-2011 could not be examined because those sources were unreadable.

   About evidence:ntp-iq-review, source:ntp-monograph-2024 The finding

3. Concern (minor) Sources are archived

   Sources walsh-cochrane-2019, wright-jada-2014, wong-cochrane-2024, taylor-jama-pediatrics-2025 and whitford-2011 have no archived copy; archive them with archive_source.

   Seven sources cited by evidence items have archived copies and were read as copy=archive: cdc-mmwr-2019, ntp-monograph-2024, childsmile-managing-fluoride, cfr-355-50, fda-ingestible-fluoride-2025, texas-ag-toothpaste-2025 and colgate-packaging-2025. Five have archiveUrl null. walsh-cochrane-2019, wong-cochrane-2024, taylor-jama-pediatrics-2025 and whitford-2011 returned HTTP 403 live and have no Wayback capture. wright-jada-2014 was read live with empty text. These five sources carry the article's benefit evidence (cochrane-toothpaste-trials, ada-under-six-review), its fluorosis evidence (cochrane-fluorosis-2024) and part of its IQ and toxicity evidence. Without archives, readers and auditors cannot check exactly what was cited.

   About source:walsh-cochrane-2019, source:wright-jada-2014, source:wong-cochrane-2024, source:taylor-jama-pediatrics-2025, source:whitford-2011 The finding

4. Not checked Citations support the evidence

   Five of the twelve sources could not be read, so I could not check the evidence items that rest on them. walsh-cochrane-2019, wong-cochrane-2024, taylor-jama-pediatrics-2025 and whitford-2011 have no archived copy and no Wayback capture, and their live URLs returned HTTP 403 (linkStatus error). A 403 is not proof a page is gone, so these are not treated as dead links. wright-jada-2014 was read live (linkStatus ok, HTTP 200), but the text came back empty. These sources are the only support for evidence:cochrane-toothpaste-trials (the benefit evidence the conclusion relies on), evidence:ada-under-six-review and evidence:cochrane-fluorosis-2024. They also share support for evidence:ntp-iq-review (Taylor) and evidence:acute-toxicity-dose (Whitford). Every source I could read exists as cited and supports its item. CDC MMWR: '>38% of children aged 3-6 years reportedly used a half or full load of toothpaste' (n=5,157), plus the smear and pea-sized (0.25 g) recommendations. NTP page: 'concluded, with moderate confidence, that higher levels of fluoride exposure, such as drinking water containing more than 1.5 milligrams of fluoride per liter, are associated with lower IQ in children', the total-exposure scope, and insufficient data at 0.7 mg/L. Childsmile: 'toxic dose ... estimated at 5 mg of fluoride per kg' and 'three quarters of a tube of 1000ppm toothpaste' for a 15 kg child. 21 CFR 355.50(c)(1): the warning text as quoted. FDA, Oct 31 2025: notices on 'unapproved fluoride-containing ingestible drugs labeled for use in children under age 3 or older children at low or moderate risk'. Texas AG, May 1 2025: CIDs to Colgate and P&G over marketing that encourages kids to ingest toothpaste. DentistryIQ: Colgate packaging showing 'pea-sized' for ages 3 to 6 and 'smear' for under 3. No archived copy was an error page, a paywall or a different document.

5. Pass Sources can support their claims

   Every source is an accountable publisher suited to its claim, judged from URL, publisher and title, and from text where available. Cochrane Database of Systematic Reviews (walsh-cochrane-2019, wong-cochrane-2024), JADA (wright-jada-2014), JAMA Pediatrics (taylor-jama-pediatrics-2025) and Karger's Monographs in Oral Science (whitford-2011) are peer-reviewed. CDC MMWR, the NTP (federal systematic review, peer-reviewed by NASEM per the page), NHS Scotland Childsmile guidance, the FDA press release and 21 CFR 355.50 (via Cornell LII) are official sources. The Texas AG press release is cited for the office's own investigation, which is a claim about its own contents. DentistryIQ is an edited trade publication with a named associate editor, cited for Colgate's packaging change, and it in turn cites the Texas AG's own release. No open-edit, opinion, satire or fiction source is used as evidence. The Wikimedia Commons credit supports only an image.

6. Pass Conclusion rests on cited evidence

   Each factual assertion in the conclusion traces to a cited evidence item. The 96 trials and the 1,000 ppm benefit trace to cochrane-toothpaste-trials. The ADA under-6 review traces to ada-under-six-review. The 2024 fluorosis findings at ages 1 to 2, mostly mild, trace to cochrane-fluorosis-2024. 'About 38 percent' traces to cdc-toothpaste-amounts. The 0.25 mg, 5 mg/kg, 50 g and 200-amount arithmetic traces to acute-toxicity-dose. The NTP moderate-confidence finding above 1.5 mg/L, the JAMA urinary association, no toothpaste-isolating study, and high risk of bias all trace to ntp-iq-review and its limitation. The FDA supplement action and the Texas investigation leading to Colgate's packaging trace to label-and-2025-actions. 'Most included studies came from areas with higher natural fluoride' is supported by the limitation ('45 of 74 were from China') and by the NTP page ('based primarily on epidemiology studies in non-U.S. countries ... where some ... received total fluoride exposure amounts higher than 1.5 mg fluoride/L'). The open question at typical U.S. levels traces to the NTP 0.7 mg/L insufficient-data finding. This check is about tracing only. Whether the unreadable sources support their items is reported under citation-supports-evidence.

Coverage: Read (archived copy, copy=archive): cdc-mmwr-2019 (full MMWR text with tables), ntp-monograph-2024 (NTP fluoride assessment page, including its meta-analysis summary), childsmile-managing-fluoride, cfr-355-50 (Cornell LII), fda-ingestible-fluoride-2025, texas-ag-toothpaste-2025, colgate-packaging-2025 (DentistryIQ). None were truncated. Not readable: walsh-cochrane-2019, wong-cochrane-2024, taylor-jama-pediatrics-2025 and whitford-2011 have no archive, their live URLs returned HTTP 403 (linkStatus error), and there is no Wayback capture (text null). These are not treated as dead links. wright-jada-2014 has no archive and was read live (linkStatus ok, HTTP 200, linkinghub.elsevier.com) but returned empty text, so its content could not be examined. The article version was published 2026-10-10T06:55Z, less than 30 days old. The image credit sources (Wikimedia Commons) were not audited because they support only images. I used only snapshot text, with no outside knowledge of the sources' contents.

1. Concern (minor) Title states the finding

   Make seoTitle state the finding, e.g. "Is Fluoride Toothpaste Bad? It Prevents Cavities; IQ Links Involve Far Higher Intake".

   Title: "Fluoride toothpaste prevents cavities; the IQ concern involves far higher fluoride intake." It names the subject, leads with what is true in positive form, does not repeat the myth, addresses the IQ part of the claim, and is neutral, so the main title meets the rule (whether "far higher" is justified is the Skeptic's question). seoTitle: "Is Fluoride Toothpaste Bad? What the Cavity, IQ and Safety Evidence Shows" uses search wording, which is allowed, but it only promises to describe the evidence and never states the finding. Rule broken: "seoTitle may use the wording people search with as long as it states the finding" (Minor: a seoTitle that does not state the finding).

   About conclusion The finding

2. Concern (minor) Verdict fields agree and stand alone

   Split the compound claim and rate its main point (e.g. "Fluoride toothpaste lowers children's IQ."), and add the open low-dose caveat to the answer to match the conclusion.

   Read as a verdict: FactHub rates the claim "Fluoride in toothpaste is bad for you: it is a neurotoxin that lowers children's IQ, which is why the tube carries a poison-control warning." Misleading (High confidence): "Used as directed, fluoride toothpaste is safe; IQ effects were linked to much higher drinking-water exposures." It reads coherently and the claim is stated as it circulates, not as its correction, and the fields do not contradict each other. Two lapses: (1) The claim bundles three assertions (bad for you; a neurotoxin that lowers IQ; the reason for the poison-control warning). Rule: "a compound claim is split and the main point rated." (2) The answer and title present the IQ link as confined to much higher drinking-water exposures, while the conclusion adds that the 2025 meta-analysis "found an inverse association with urinary fluoride even at lower levels", that the research "does not cleanly exonerate toothpaste swallowed in excess", and that whether typical U.S. intake affects cognition "is open". Rule: the answer "stands alone when quoted" and all verdict fields "express the same conclusion"; quoted alone, the answer omits the caveat the conclusion treats as central. Not a contradiction, so Minor.

   About conclusion, evidence:ntp-iq-review The finding

3. Concern (minor) Each section does its job

   Cut the summary to one sentence naming the Cochrane trial evidence and the NTP total-intake finding; move the risk and dosing guidance to keyPoints or context.

   Rule: "summary is one sentence naming the strongest independent lines of evidence." The summary is five sentences (about 150 words) and carries background and guidance that belong elsewhere: "The controversy comes mostly from...", "Toothpaste is meant to be spat out, but young children swallow some of it...", and "which is why health agencies recommend a rice-grain smear under age 3 and a pea-sized amount from 3 to 6", much of which duplicates keyPoints. Minor: one field carrying content that belongs elsewhere. Other fields pass: keyPoints state what the evidence establishes; context is one paragraph of framing and scope; the conclusion synthesizes the benefit, fluorosis, acute-dose and IQ lines, weighs limitations (no study isolates toothpaste, high risk of bias), states what remains unproven, and gives confidence; the editorialNote states scope, caveats ("Regulatory actions are current as of the review date") and review status ("No external specialist review has been recorded"). No hand-written independence note.

   About conclusion The finding

4. Concern (minor) Consistent house style

   Change "programme" to "program"; spell out ppm (parts per million), CDC, ADA and NHANES at first use; explain dental fluorosis at its first mention in the summary.

   Rule: American English spelling; an abbreviation is spelled out at first use; technical terms explained at first use. (1) Evidence acute-toxicity-dose: "Scotland's Childsmile programme" uses British spelling (proper name is Childsmile; "programme" is generic). (2) "ppm" is used from the description onward ("1,000 ppm") and never spelled out. "CDC" first appears in keyPoints ("in a CDC survey") and "ADA" in the conclusion and evidence ("ADA-commissioned review") without being spelled out in reader text; "NHANES" appears in the cdc-toothpaste-amounts method and image alt text unexplained. (3) "dental fluorosis" appears in the summary and keyPoints without explanation; it is only explained later in the conclusion ("a change in tooth enamel..."). "Network meta-analysis" is also unexplained. Minor: unexplained abbreviations and terms and a spelling inconsistency. Numbers (1,000 ppm, 32,181, 38 percent, 0.25 mg, 1.5 mg/L) are consistent throughout, and no leftover drafting text was found.

   About conclusion, evidence:acute-toxicity-dose, evidence:cdc-toothpaste-amounts, evidence:ada-under-six-review, evidence:cochrane-toothpaste-trials The finding

5. Pass Limitations are specific

   Every limitation is specific to its item and says what it does not prove: the Cochrane trials limitation notes decades-old pediatric trials, thinner adult and primary-tooth evidence, manufacturer involvement, and "measures benefit, not long-term safety"; the ADA review notes limited young-child evidence and that it predates the 2024 to 2025 reviews; the fluorosis review notes observational designs and low-certainty evidence on age and amount; the CDC survey notes parent-reported amounts and "exposure patterns, not health outcomes"; the NTP item notes cross-sectional designs, 45 of 74 studies from China, 52 at high risk of bias, and that no study isolated toothpaste; the dose item notes the threshold is not a precise boundary and the arithmetic's assumptions; the regulatory item notes policy actions are not experimental evidence and the Texas matter was not a court finding. None is boilerplate.

6. Pass Tone is measured and respectful

   Language is measured: "probably increases", "moderate confidence", "associated with", "that question is open". Objection responses are short, evidence-based and respectful, e.g. "that finding deserves to be taken seriously" and "Fluorosis is a real effect of swallowing too much fluoride". No ridicule, sarcasm or contempt. "Used as directed, fluoride toothpaste is safe" is qualified by its condition rather than an unqualified absolute; no "proves", "definitively" or "impossible".

7. Pass Readers can verify it

   All twelve sources have role labels (e.g. "Systematic review of randomized trials", "Federal systematic review", "Non-U.S. public-health guidance", "Trade press report"), full titles, DOIs, PMIDs, CFR citations or archived URLs, and descriptions of why each was chosen (e.g. "the main evidence for the benefit", "chosen because it addresses young children directly"). Key claims are anchored to primary material: Cochrane DOIs for benefit and fluorosis, NTP Monograph 08 DOI, JAMA Pediatrics DOI, 21 CFR 355.50 for the label text, FDA and Texas AG press releases with archives. Method steps cover claim definition (step 1), prioritizing systematic reviews over single studies (step 2), sources reviewed (step 3), and recording limits (step 5).

Coverage: Examined the full article payload: title, seoTitle, description, claim, finding, answer, confidence, summary, keyPoints, context, conclusion, all seven evidence items and limitations, five objections and responses, five method steps, editorialNote, image captions and alt text, and all twelve sources' role, title, identifier and description. Per the Standards prompt, source texts and the live web were not consulted; substance (whether the rating, confidence or title strength is justified, source accuracy, evidence independence) was left to the Skeptic and Source Checker. Metadata fields (dates, identifiers, URLs, changelog) were excluded from house-style comparison.